KPTI - Karyopharm Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $7.64. This is a potential upside of $6.54 (594.55%) from yesterday's end of day stock price of $1.1.

Karyopharm Therapeutics's activity chart (see below) currently has 17 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28.55% with an average time for these price targets to be met of 84.73 days.

Highest price target for KPTI is $8, Lowest price target is $4, average price target is $7.64.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 01-Mar-2024. First documented stock forecast 02-Jun-2015.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$6.69 (510.69%)

16

1 months 18 days ago

0/5 (0%)

$6.81 (572.27%)

Hold

4

$2.69 (205.34%)

10

8 months 12 days ago

6/11 (54.55%)

$2.39 (148.45%)

305

Hold

5

$3.69 (281.68%)

6

1 years 3 months 9 days ago

3/7 (42.86%)

$2.13 (74.22%)

225

Buy

14

$12.69 (968.70%)

22

1 years 8 months 14 days ago

0/5 (0%)

$9.32 (199.15%)

Hold

8

$6.69 (510.69%)

2 years 2 months 10 days ago

6/6 (100%)

$-1.06 (-11.70%)

85

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KPTI (Karyopharm Therapeutics) average time for price targets to be met?

On average it took 84.73 days on average for the stock forecasts to be realized with a an average price target met ratio 28.55

Which analyst has the current highest performing score on KPTI (Karyopharm Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on KPTI (Karyopharm Therapeutics)?

Michael Ulz works at MORGAN STANLEY and has 2 price targets and 3 ratings on KPTI

Which analyst is the currently most bullish on KPTI (Karyopharm Therapeutics)?

Maury Raycroft with highest potential upside - $33.69

Which analyst is the currently most reserved on KPTI (Karyopharm Therapeutics)?

David Lebowitz with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?